Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Paroxetine hydrochloride equivalent to 20 mg paroxetine free base in 10 mL Suspension, oral SmithKline Beecham Pharmaceuticals, Manor Royal, Crawley, Sussex, England Aropax 20 Benazepril hydrochloride 5 mg, 10 mg, 20 mg Tablet, divisible Novartis Pharma Stein AG/SA Inc., Stein, Switzerland Cibacen Benazepril hydrochloride 10 mg, 20 mg Tablet Novartis Pharma Stein AG/SA Inc., Stein, Switzerland Cibacen Carvedilol 6.25 mg, 12.5 mg, 25 mg Tablet Boehringer Mannheim GmbH., Mannheim, Germany Dilatrend Component 1: Estradiol 50 mcg Component 2: Estradiol 50 mcg, norethisterone acetate 250 mcg Transdermal patch Novartis Pharma Stein AG/SA Inc., Stein, Switzerland Estracombi TTS Tablet: Norethisterone acetate 1 mg Transdermal patch: Oestradiol 50 mcg Combination pack (tablet, transdermal patch) Novartis Pharma Stein AG/SA Inc., Stein, Switzerland Estrapak Famciclovir 125 mg, 250 mg Tablets SmithKline Beecham Pharmaceuticals, Magpie Wood, Mannor Royal, Crawley, Sussex, England Famvir Eformoterol fumerate 12 mcg per actuation Spray, oral, metered dose 3M Health Care Limited, Loughborough, Leicestershire, England Foradil Tinzaparin sodium 10 000, 20 000 anti-Xa IU/mL in 2 mL Injection, vial Leo Pharmaceutical Products, Ballerup, Denmark and Laboratoires Leo SA., Vernouillet, France innohep Tinzaparin sodium 10 000 anti-Xa IU/mL in 0.35 mL, 0.45 mL Injection, pre-filled syringe Leo Pharmaceutical Products, Ballerup, Denmark and Laboratoires Leo SA., Vernouillet, France innohep Lamotrigine 25 mg, 50 mg, 100 mg, 200 mg Tablet, dispersible/ chewable Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom and Glaxo Wellcome Australia Limited, Boronia, Victoria, Australia Lamictal Lamotrigine 5 mg Tablet, dispersible/ chewable Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom Lamictal Lamotrigine 25 mg, 50 mg, 100 mg, 200 mg Tablet Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom Lamictal Pancreatin with proteolytic activity equivalent to not less than 950 mcg tyrosine/min/mL Solution, contact lens Alcon Iberhis SA., Madrid, Spain Opti-Plus Active Cleaner Xylometazoline hydrochloride 0.1% w/v in 10 mL Drops, nasal Novartis Consumer Health SA., Prangins, Nyon, Switzerland Otrivine Menthol Xylometazoline hydrochloride 0.1% w/v in 10 mL Spray, nasal, metered Novartis Consumer Health SA., Prangins, Nyon, Switzerland Otrivine Menthol Xylometazoline hydrochloride 0.1% w/v in 10 mL Spray, nasal Novartis Consumer Health SA., Prangins, Nyon, Switzerland Otrivine Menthol Famotidine 10 mg Tablet, chewable McNeil Consumer Products Company, Round Rock, Texas, United States of America; Merck & Co Inc., West Point, Pennyslvania, United States of America and Woelm Pharma GmbH & Co., Eschwege, Germany Pepcid AC Dated this 11th day of April 1997. G. R. BOYD, Chief Advisor, Regulation and Safey, pursuant to delegation given by the Minister of Health on 20 February 1997.